Department of Otorhinolaryngology, Head and Neck Surgery, Turku University Central Hospital, 20520 Turku, Finland.
Eur Arch Otorhinolaryngol. 2010 Aug;267(8):1299-304. doi: 10.1007/s00405-010-1225-z. Epub 2010 Mar 16.
Various techniques have been used to repair maxillary defects. The aim of this study was to evaluate the suitability of pedicled temporal musculoperiosteal flap (PTMF) and free calvarial bone graft for the reconstruction of maxillary defects. In this retrospective series, 34 patients operated on from 1995 to 2006 at Turku University Central Hospital because of defects of maxilla reconstructed using PTMF with or without free calvarial bone graft were evaluated. The diagnosis, the indication for surgery, the location and staging of the tumours, and the type of radiotherapy used were reviewed. The classification of the maxillary defects was performed according to the classification of Brown (Br J Oral Maxillofac Surg 40:183-190, 2002) and the success rates of the reconstructions were evaluated. Of the patients, 32 had been operated on due to a malignant tumour, one due to a benign tumour and one due to posttraumatic palatal defect. Preoperative radiotherapy (n = 14), preoperative chemoradiotherapy (n = 2) or postoperative radiotherapy (n = 11) had been used in the tumour group. As a reconstructive method, PTMF had been used with (n = 21) or without (n = 13) free calvarial bone graft. The use of free calvarial bone graft did not have a significant effect on flap survival. At 1-month follow-up, the flap survival in the 32 patients was 71.9%, whereas 28.1% of the patients suffered from partial flap loss, but there was no total flap loss. At 6-month follow-up, the flap survival in 26 patients was 76.9%, whereas 7.7% of the patients suffered from partial flap loss, and there were four (15.4%) total flap losses. If unilateral alveolar maxillectomy had been performed (Brown classification a), at 1-month follow-up, the flap survival was 82.6%, 17.4% of the patients suffered from partial flap loss, and there was no total flap loss. At 6-month follow-up, the flap survival was 89.5%, while 10.5% of the patients suffered from partial flap loss, and there was no total flap loss. The application of PTMF with or without free calvarial bone graft for reconstruction of limited palatal and maxillary defects appears to be feasible.
各种技术已被用于修复上颌骨缺损。本研究旨在评估带蒂颞肌筋膜瓣(PTMF)和游离颅骨骨移植在重建上颌骨缺损中的适用性。在这项回顾性系列研究中,对 1995 年至 2006 年在图尔库大学中心医院因使用 PTMF 或 PTMF 联合游离颅骨骨移植修复上颌骨缺损而接受手术的 34 例患者进行了评估。回顾了诊断、手术适应证、肿瘤的位置和分期以及放疗类型。上颌骨缺损的分类采用 Brown 分类(Br J Oral Maxillofac Surg 40:183-190, 2002)进行,评估了重建的成功率。患者中,32 例因恶性肿瘤、1 例因良性肿瘤和 1 例因创伤后腭部缺损而接受手术。肿瘤组中术前放疗(n=14)、术前放化疗(n=2)或术后放疗(n=11)。作为重建方法,PTMF 联合(n=21)或不联合(n=13)游离颅骨骨移植。游离颅骨骨移植的使用对皮瓣存活率没有显著影响。在 1 个月的随访中,32 例患者的皮瓣存活率为 71.9%,28.1%的患者出现部分皮瓣坏死,但无全层皮瓣坏死。在 6 个月的随访中,26 例患者的皮瓣存活率为 76.9%,7.7%的患者出现部分皮瓣坏死,4 例(15.4%)出现全层皮瓣坏死。如果行单侧牙槽骨上颌骨切除术(Brown 分类 a),在 1 个月的随访中,皮瓣存活率为 82.6%,17.4%的患者出现部分皮瓣坏死,无全层皮瓣坏死。在 6 个月的随访中,皮瓣存活率为 89.5%,10.5%的患者出现部分皮瓣坏死,无全层皮瓣坏死。PTMF 联合或不联合游离颅骨骨移植用于重建有限的腭部和上颌骨缺损似乎是可行的。